Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243638 | SCV001416807 | likely benign | Spastic paraplegia | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004034757 | SCV004943958 | uncertain significance | Inborn genetic diseases | 2023-12-29 | criteria provided, single submitter | clinical testing | The c.3443A>C (p.K1148T) alteration is located in exon 10 (coding exon 9) of the SACS gene. This alteration results from a A to C substitution at nucleotide position 3443, causing the lysine (K) at amino acid position 1148 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001835177 | SCV002086695 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2020-01-14 | no assertion criteria provided | clinical testing |